Investegate | Company Announcement

Investegate announcements from Ipsen updates on E.U. Marketing Authorisation Application for odevixibat in Alagille syndrome

Related Keywords

France ,Paris ,France General ,Belgium ,Saclay ,China ,Italy ,Cambridge ,Cambridgeshire ,United Kingdom ,Shanghai ,United States ,Germany ,America ,American ,Asia Pacific ,Ipsen Euronext ,Christelle Huguet ,Jennifer Moore ,Amy Wolf ,Ioana Piscociu ,Nicolas Bogler ,European Medicines Agency ,Albireo Pharma Inc ,European Society For Pediatric Gastroenterology Hepatology ,Committee For Medicinal Products Human ,Development For Ipsen ,Head Of Research ,Committee For Orphan Medicinal Products ,Global Corporate Communications ,Committee For Medicinal Products Human Use ,Head Of Corporate Brand Strategy Communications ,Authorisation Application ,Medicinal Products ,Human Use ,Orphan Medicinal Products ,Marketing Authorisation Application ,Executive Vice President ,Orphan Medicinal Product Regulation ,Pediatric Gastroenterology Hepatology ,North America ,Middle East ,Reported Outcome ,Safety Information ,Test Abnormalities ,Soluble Vitamin ,Rare Disease ,Sponsored Level ,American Depositary Receipt ,Investor Relations ,Relations Manager ,Corporate Brand Strategy ,Global Media Relations ,French Autorit ,Des March ,Universal Registration Document ,Announcements ,Nvestegate Alerts ,K Wire ,Uk News ,Ews Alerts ,Mail News Alerts ,Tse News Alerts ,Tse Email Alerts ,Echmark Announcements ,Tse ,Regulatory News ,Ns Announcements ,Quities ,Quity News ,Quity Announcements ,Company News ,Hares ,Corporate News ,Orporate Financial News ,Orporate News Releases ,Orporate Finance News ,Usiness News ,